查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574996

医院获得性疾病检测市场，按感染类型、检测技术、检测类型、最终用户、国家和地区划分 - 2024-2032 年行业分析、市场规模、市场份额和预测

Hospital-Acquired Disease Testing Market, By Infection Type, By Testing Technology, By Test Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年医院获得性疾病检测市场规模为122.9032亿美元，2024年至2032年复合年增长率为15.90%。

医院获得性疾病检测市场-市场动态

医院获得性感染发生率的上升推动了医院获得性疾病检测市场对先进检测解决方案的需求

医院获得性感染 (HAI) 发病率的上升大大增加了医疗保健环境中对先进检测解决方案的需求。这些感染，如泌尿道感染 (UTI)、手术部位感染和血液感染，对患者健康构成严重风险，并导致住院时间延长和死亡率升高。据美国疾病管制与预防中心 (CDC) 称，医院感染每年影响数百万患者，促使开发更精确、更快速的诊断工具。世界各地的政府和医疗机构已经发起了对抗医院感染的措施。例如，世界卫生组织（WHO）推行严格的卫生规程，而英国等国家则对感染率高的医院实施经济处罚。人们越来越关注即时、准确的检测方法，例如聚合酶炼式反应 (PCR) 和快速诊断检测，预计将推动医院获得性疾病检测的进一步进步。

医院获得性疾病检测市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 15.90% 左右的复合年增长率成长

基于感染类型细分，尿路感染。预计在 2023 年实现最大市场份额

基于检测技术细分，PCR（聚合酶炼式反应）。是2023年的主导类型

根据测试类型细分，分子诊断是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

医院获得性疾病检测市场-細項分析：

全球医院获得性疾病检测市场根据感染类型、检测技术、检测类型、最终用户和地区进行细分。

依感染类型，市场分为四类：泌尿道感染、手术部位感染、呼吸道感染、血流感染。泌尿道感染（UTI）因其在医疗机构中的盛行率而排名最高，其次是手术部位感染，这是术后的关键问题。其次是呼吸道感染，其中血流感染最不常见，但也很严重。

根据测试技术，市场分为四类：PCR（聚合酶炼式反应）、ELISA（酵素连结免疫吸附测定）、微生物培养和快速诊断。 PCR（聚合酶炼式反应）因其准确性和速度而领先，其次是广泛用于抗体检测的 ELISA（酶联免疫吸附测定）。微生物培养位居第二，快速诊断的优先顺序最低。

医院获得性疾病检测市场-地理洞察

医院获得性疾病检测市场呈现出显着的地区差异，其中北美领先，因为其先进的医疗基础设施和医院获得性感染(HAI) 的高发生率，大约每31 名住院患者中就有1 人受到感染。在严格的法规和感染控制措施意识增强的推动下，欧洲紧随其后。在亚太地区，快速的城市化和医疗设施的扩张促进了市场的成长，特别是在印度和中国等国家，医院获得性感染正成为一个紧迫的问题。世界卫生组织的全球感染预防和控制网络等措施旨在加强资源匮乏地区医院感染的监测和管理，进一步刺激需求。同时，随着医院升级检测能力以应对不断上升的感染率，拉丁美洲和中东地区的感染率也不断增长。这些地区越来越多地采用先进的诊断技术，展现了提高医疗机构病患安全和照护品质的全球趋势。

医院获得性疾病检测市场-竞争格局：

医院获得性疾病检测市场的特点是竞争格局激烈，雅培实验室、罗氏诊断公司和生物梅里埃等主要参与者在北美处于领先地位，北美由于其广泛的医疗保健系统和对诊断技术的大量投资而成为主导地区。欧洲紧随其后，西门子 Healthineers 和赛默飞世尔科技 (Thermo Fisher Scientific) 等公司正在透过策略合作伙伴关係和感染检测方法的创新来巩固自己的地位。在亚太地区，由于医院获得性感染发生率不断上升，印度和中国等国家不断提高检测能力，以满足不断增长的需求，本土企业不断涌现。值得注意的是，印度政府推出了加强医院感染控制措施的倡议，进一步推动了市场成长。同时，在拉丁美洲和中东，公司正致力于扩大其分销网络并提高对 HAI 的认识，从而促进市场动态。总体而言，竞争格局的特点是创新和策略合作，旨在改善不同医疗保健环境中的患者治疗结果。

最新进展：

2021 年 11 月，PINC AI™ Applied Sciences 和 Molnlycke Health Care AB 启动了一项临床试验，以评估 Molnlycke 的 Mepilex Border Flex 敷料在减少急诊环境中医院获得性压力性损伤 (HAPI) 方面的有效性。

目录

第一章：医院获得性疾病检测市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按感染类型分類的医院获得性疾病检测市场片段
    • 医院获得性疾病检测市场片段（按检测技术）
    • 按测试类型分類的医院获得性疾病检测市场片段
    • 最终用户的医院获得性疾病检测市场片段
    • 按国家/地区分類的医院获得性疾病检测市场片段
    • 按地区分類的医院获得性疾病检测市场片段
  • 竞争洞察

第 3 章：医院获得性疾病检测主要市场趋势

  • 医院获得性疾病检测市场驱动因素
    • 市场驱动因素的影响分析
  • 医院获得性疾病检测市场限制
    • 市场限制影响分析
  • 医院获得性疾病检测市场机会
  • 医院获得性疾病检测市场未来趋势

第 4 章：医院获得性疾病检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：医院获得性疾病检测市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：医院获得性疾病检测市场格局

  • 2023 年医院获得性疾病检测市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：医院获得性疾病检测市场 - 按感染类型

  • 概述
    • 按感染类型分類的细分市场占有率分析
    • 泌尿道感染
    • 手术部位感染
    • 呼吸道感染
    • 血流感染

第 8 章：医院获得性疾病检测市场 - 按检测技术分类

  • 概述
    • 透过测试技术进行细分市场份额分析
    • PCR（聚合酶炼式反应）
    • ELISA（酵素连结免疫吸附测定）
    • 微生物培养
    • 快速诊断

第 9 章：医院获得性疾病检测市场 - 按检测类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 分子诊断
    • 免疫测定
    • 常规培养测试

第 10 章：医院获得性疾病检测市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊断实验室
    • 门诊手术中心
    • 学术及研究机构

第 11 章：医院获得性疾病检测市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美医院获得性疾病检测主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按感染类型）
    • 北美市场规模和预测（按测试技术）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲医院获得性疾病检测主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按感染类型）
    • 欧洲市场规模和预测（透过测试技术）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区医院获得性疾病检测主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按感染类型）
    • 按测试技术分類的亚太市场规模和预测
    • 按测试类型分類的亚太市场规模和预测
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲医院获得性疾病检测主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按感染类型）
    • 拉丁美洲市场规模和预测（透过测试技术）
    • 拉丁美洲市场规模和预测（按测试类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲医院获得性疾病检测主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按感染类型）
    • 中东和非洲市场规模及预测（按测试技术）
    • 中东和非洲市场规模及预测（按测试类型）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第12章：主要供应商分析-医院获得性疾病检测产业

  • 竞争仪表板
  • 公司简介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Cardinal Health, Inc.
    • Cepheid Inc. (A Danaher Company)
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • GenMark Diagnostics, Inc.
    • Hologic, Inc.
    • Luminex Corporation
    • Merck KGaA
    • Qiagen NV
    • QuidelOrtho Corporation
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3983

REPORT HIGHLIGHT

Hospital-Acquired Disease Testing Market size was valued at USD 12,290.32 Million in 2023, expanding at a CAGR of 15.90% from 2024 to 2032.

The Hospital-Acquired Disease Testing Market focuses on diagnostic tests for infections acquired in healthcare settings, impacting patient safety and hospital resources. Rising incidences of hospital-acquired infections (HAIs), such as MRSA and C. difficile, emphasize the need for effective testing solutions; for instance, HAIs affect approximately 1 in 31 hospital patients in the U.S., highlighting significant challenges for healthcare providers. Increasing awareness about infection control and advancements in molecular diagnostics are key drivers for market growth. However, factors such as high testing costs and stringent regulatory frameworks may hinder adoption. Opportunities abound in developing innovative rapid testing methods and expanding testing capabilities, particularly in emerging markets where healthcare infrastructure is improving. As hospitals prioritize patient safety and regulatory compliance, investments in advanced testing technologies are expected to rise, fostering a more proactive approach to infection management.

Hospital-Acquired Disease Testing Market- Market Dynamics

Rising Incidences of Hospital-Acquired Infections Propel Demand for Advanced Testing Solutions in the Hospital-Acquired Disease Testing Market

The rising incidence of hospital-acquired infections (HAIs) has significantly increased the demand for advanced testing solutions in healthcare settings. These infections, such as urinary tract infections (UTIs), surgical site infections, and bloodstream infections, pose severe risks to patient health and have led to extended hospital stays and higher mortality rates. According to the Centers for Disease Control and Prevention (CDC), HAIs affect millions of patients annually, prompting the development of more precise and rapid diagnostic tools. Governments and healthcare organizations worldwide have launched initiatives to combat HAIs. For instance, the World Health Organization (WHO) promotes stringent hygiene protocols, while countries like the UK have introduced financial penalties for hospitals with high infection rates. The increasing focus on real-time, accurate testing methods, such as Polymerase Chain Reaction (PCR) and rapid diagnostic tests, is expected to drive further advancements in hospital-acquired disease testing.

Hospital-Acquired Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.90% over the forecast period (2024-2032)

Based on Infection type segmentation, Urinary Tract Infections. was predicted to show maximum market share in the year 2023

Based on Testing Technology segmentation, PCR (Polymerase Chain Reaction). was the leading type in 2023

Based on Test Type segmentation, Molecular Diagnostics was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Hospital-Acquired Disease Testing Market- Segmentation Analysis:

The Global Hospital-Acquired Disease Testing Market is segmented on the basis of Infection type, Testing Technology, Test Type, End-User, and Region.

The market is divided into four categories based on Infection type: Urinary Tract Infections, Surgical Site Infections, Respiratory Infections, and Bloodstream Infections. Urinary Tract Infections (UTIs) rank highest due to their prevalence in healthcare settings, followed by Surgical Site Infections, which are critical post-operative concerns. Respiratory Infections come next, with Bloodstream Infections being the least common yet severe.

The market is divided into four categories based on Testing Technology: PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), Microbial Culture, and Rapid Diagnostics. PCR (Polymerase Chain Reaction) leads due to its accuracy and speed, followed by ELISA (Enzyme-Linked Immunosorbent Assay), which is widely used for antibody detection. Microbial Culture ranks next, with Rapid Diagnostics being the least prioritized.

Hospital-Acquired Disease Testing Market- Geographical Insights

The Hospital-Acquired Disease Testing Market shows significant regional variation, with North America leading due to its advanced healthcare infrastructure and high incidence of hospital-acquired infections (HAIs), which affect approximately 1 in 31 hospitalized patients. Europe follows closely, driven by stringent regulations and increased awareness of infection control measures. In Asia-Pacific, rapid urbanization and the expansion of healthcare facilities contribute to market growth, particularly in countries like India and China, where hospital-acquired infections are becoming a pressing concern. Initiatives such as the World Health Organization's Global Infection Prevention and Control Network aim to enhance surveillance and management of HAIs in low-resource settings, further stimulating demand. Meanwhile, Latin America and the Middle East are witnessing growth as hospitals upgrade their testing capabilities to combat rising infection rates. These regions are increasingly adopting advanced diagnostic technologies, showcasing a global trend towards improving patient safety and quality of care in healthcare settings.

Hospital-Acquired Disease Testing Market- Competitive Landscape:

The Hospital-Acquired Disease Testing Market is characterized by a competitive landscape with key players such as Abbott Laboratories, Roche Diagnostics, and bioMerieux leading in North America, which is the dominant region due to its extensive healthcare systems and significant investment in diagnostic technologies. Europe follows, where companies like Siemens Healthineers and Thermo Fisher Scientific are strengthening their positions through strategic partnerships and innovations in infection detection methods. In the Asia-Pacific region, local players are emerging, driven by the increasing prevalence of hospital-acquired infections, with countries like India and China ramping up their testing capabilities to meet rising demand. Notably, the Indian government has launched initiatives to enhance infection control practices in hospitals, further boosting market growth. Meanwhile, in Latin America and the Middle East, companies are focusing on expanding their distribution networks and increasing awareness about HAIs, contributing to market dynamics. Overall, the competitive landscape is marked by innovation and strategic collaborations aimed at improving patient outcomes across diverse healthcare settings.

Recent Developments:

In November 2021, PINC AI(TM) Applied Sciences and Molnlycke Health Care AB launched a clinical trial to evaluate the effectiveness of Molnlycke's Mepilex Border Flex dressings in reducing hospital-acquired pressure injuries (HAPIs) in acute care settings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Becton, Dickinson, and Company
  • bioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • Cepheid Inc. (A Danaher Company)
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GenMark Diagnostics, Inc.
  • Hologic, Inc.
  • Luminex Corporation
  • Merck KGaA
  • Qiagen N.V.
  • QuidelOrtho Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY INFECTION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Urinary Tract Infections
  • Surgical Site Infections
  • Respiratory Infections
  • Bloodstream Infections

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY TESTING TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • PCR (Polymerase Chain Reaction)
  • ELISA (Enzyme-Linked Immunosorbent Assay)
  • Microbial Culture
  • Rapid Diagnostics

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Immunoassays
  • Conventional Culture Tests

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Ambulatory Surgery Centers
  • Academic & Research Institutes

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hospital-Acquired Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hospital-Acquired Disease Testing Market Snippet by Infection type
    • 2.1.2. Hospital-Acquired Disease Testing Market Snippet by Testing Technology
    • 2.1.3. Hospital-Acquired Disease Testing Market Snippet by Test Type
    • 2.1.4. Hospital-Acquired Disease Testing Market Snippet by End-User
    • 2.1.5. Hospital-Acquired Disease Testing Market Snippet by Country
    • 2.1.6. Hospital-Acquired Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Hospital-Acquired Disease Testing Key Market Trends

  • 3.1. Hospital-Acquired Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hospital-Acquired Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hospital-Acquired Disease Testing Market Opportunities
  • 3.4. Hospital-Acquired Disease Testing Market Future Trends

4. Hospital-Acquired Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hospital-Acquired Disease Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hospital-Acquired Disease Testing Market Landscape

  • 6.1. Hospital-Acquired Disease Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hospital-Acquired Disease Testing Market - By Infection type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Infection type, 2023 & 2032 (%)
    • 7.1.2. Urinary Tract Infections
    • 7.1.3. Surgical Site Infections
    • 7.1.4. Respiratory Infections
    • 7.1.5. Bloodstream Infections

8. Hospital-Acquired Disease Testing Market - By Testing Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Testing Technology, 2023 & 2032 (%)
    • 8.1.2. PCR (Polymerase Chain Reaction)
    • 8.1.3. ELISA (Enzyme-Linked Immunosorbent Assay)
    • 8.1.4. Microbial Culture
    • 8.1.5. Rapid Diagnostics

9. Hospital-Acquired Disease Testing Market - By Test Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 9.1.2. Molecular Diagnostics
    • 9.1.3. Immunoassays
    • 9.1.4. Conventional Culture Tests

10. Hospital-Acquired Disease Testing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Ambulatory Surgery Centers
    • 10.1.5. Academic & Research Institutes

11. Hospital-Acquired Disease Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Hospital-Acquired Disease Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Hospital-Acquired Disease Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Hospital-Acquired Disease Testing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Hospital-Acquired Disease Testing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Hospital-Acquired Disease Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Hospital-Acquired Disease Testing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Becton, Dickinson and Company
    • 12.2.3. bioMerieux S.A.
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. Cardinal Health, Inc.
    • 12.2.6. Cepheid Inc. (A Danaher Company)
    • 12.2.7. Danaher Corporation
    • 12.2.8. F. Hoffmann-La Roche AG
    • 12.2.9. GenMark Diagnostics, Inc.
    • 12.2.10. Hologic, Inc.
    • 12.2.11. Luminex Corporation
    • 12.2.12. Merck KGaA
    • 12.2.13. Qiagen N.V.
    • 12.2.14. QuidelOrtho Corporation
    • 12.2.15. Siemens Healthineers AG
    • 12.2.16. Thermo Fisher Scientific Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us